Level C· Early human research exploring benefitsProspective StudyPubMed

Evidence for skeletal progenitor cells in the degenerate human intervertebral disc.

Risbud MV., Guttapalli A., Tsai TT., Lee JY., Danielson KG., Vaccaro AR.

Prospective Study with a reported sample of 5 on Back Pain, Disc Degeneration, published in Spine (Phila Pa 1976) (2007) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Spine (Phila Pa 1976) (2007)
Country
United States
Reported sample size
5
Source database
PubMed
PMID
17978651
DOI
10.1097/BRS.0b013e318158dea6

Abstract (original English)

To identify and characterize endogenous progenitor cell population from intervertebral disc. To determine if progenitor cells exist in degenerate human discs. Back pain, a significant source of morbidity in our society, is directly linked to the pathology of the intervertebral disc. Because disc disease is accompanied by a loss of cellularity, there is considerable interest in regeneration of cells of both the anulus fibrosus (AF) and nucleus pulposus (NP). To determine if skeletal progenitor cells are present in the disc, samples were obtained from the degenerate AF and NP of 5 patients (Thompson grade 2 and 3, mean age 34 +/- 7.6 years) undergoing anterior cervical discectomy and fusion procedures as well as adult rat lumbar spine. Cells isolated from degenerate human tissues expressed CD105, CD166, CD63, CD49a, CD90, CD73, p75 low affinity nerve growth factor receptor, and CD133/1, proteins that are characteristic of marrow mesenchymal stem cells. In osteogenic media, there was an induction of alkaline phosphatase activity and expression of alkaline phosphatase, osteocalcin, and Runx-2 mRNA. When maintained in adipogenic media, a small percentage of cells displayed evidence of adipogenic differentiation: accumulation of cytosolic lipid droplets and increased expression of peroxisome proliferator-activated receptor-gamma2 and lipoprotein lipase mRNA. AF- and NP-derived cells

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdipocytesAdultAlkaline PhosphataseAnimalsAntigens, CDBone and BonesCell DifferentiationCell SeparationCells, CulturedCervical Vertebrae

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research